Titlebook: Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics; Kevin M. Koo Book 2019 Springer Nature Switzerland AG 2019 Pr

莊嚴(yán)

Criteria

exclusice

triptans

Summary and Future Work,In conclusion, with the goal to improve PCa early detection for better disease risk stratification in the clinic, this book has advanced both the fields of clinical PCa screening methodologies and accurate non-invasive identification of aggressive PCa subtypes from urine samples.

Permanent

https://doi.org/10.1007/978-3-030-31000-4Prostate Cancer Detection; Precision Medicine; Urinary Nanodiagnostics; Clinical Translation; Biosensor

DEFER

978-3-030-31002-8Springer Nature Switzerland AG 2019

ABHOR

Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics978-3-030-31000-4Series ISSN 2190-5053 Series E-ISSN 2190-5061

糾纏

Phil Howlett,Julia Piantadosi,Charles PearceG detection in patient urinary samples by coupling the isothermal reverse transcription-recombinase polymerization amplification (RT-RPA) to amplify TMPRSS2-ERG transcripts and directly detect the amplicons using surface-enhanced Raman scattering (SERS).

保留

Parabola

2190-5053 roduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development..978-3-030-31002-8978-3-030-31000-4Series ISSN 2190-5053 Series E-ISSN 2190-5061